GLP-1 across different reward facets Since the convergence of meta-analytic results for GLP-1 was too low to provide support for a neuromodulatory role in food reward processing, it may be instructive to compare specific phases
This hormone has a significant impact on the physiological processes involved in weight management, blood sugar regulation, and appetite and food intake control
Semaglutide is currently approved for patients who are 12 years of age or older, and tirzepatide is currently approved for patients who are 18 years of age or older
This review is part of the PlexusDx Education Hub, a resource covering GLP-1 therapies, weight-management protocols, and the genetic variables that influence how any program performs
We create a weight loss plan customized to your specific biology, risk factors, and history